XML 61 R44.htm IDEA: XBRL DOCUMENT
v3.25.0.1

CAPITAL STOCK (Tables) | 12 Months Ended
--- | ---
Dec. 28, 2024
Equity [Abstract] |
Schedule of Net Earnings (Loss) Attributable to Common Shareowners and Weighted-Average Shares outstanding | The following table reconciles net earnings (loss) attributable to common shareowners and the weighted-average shares outstanding used to calculate basic and diluted earnings (loss) per share for the fiscal years ended December 28, 2024, December 30, 2023, and December 31, 2022.
| 2024 |  | 2023 |  | 2022
Numerator (in millions): |  |  |  |  |
Net Earnings (Loss) from Continuing Operations Attributable to Common Shareowners | $ | 286.3 |  |  | $ | (281.7) |  |  | $ | 164.3 |
Add: Contract adjustment payments accretion | — |  |  | — |  |  | 1.2 |
Net Earnings (Loss) from Continuing Operations Attributable to Common Shareowners - Diluted | 286.3 |  |  | (281.7) |  |  | 165.5 |
Net earnings (loss) from discontinued operations | 8.0 |  |  | (28.8) |  |  | 892.4 |
Net Earnings (Loss) Attributable to Common Shareowners - Diluted | $ | 294.3 |  |  | $ | (310.5) |  |  | $ | 1,057.9 |
| 2024 |  | 2023 |  | 2022
Denominator (in thousands): |  |  |  |  |
Basic weighted-average shares outstanding | 150,485 |  |  | 149,751 |  |  | 148,170 |
Dilutive effect of stock contracts and awards | 812 |  |  | — |  |  | 8,383 |
Diluted weighted-average shares outstanding | 151,297 |  |  | 149,751 |  |  | 156,553 |
Earnings (loss) per share of common stock: |  |  |  |  |
Basic earnings (loss) per share of common stock: |  |  |  |  |
Continuing operations | $ | 1.90 |  |  | $ | (1.88) |  |  | $ | 1.11 |
Discontinued operations | $ | 0.05 |  |  | $ | (0.19) |  |  | $ | 6.02 |
Total basic earnings (loss) per share of common stock | $ | 1.96 |  |  | $ | (2.07) |  |  | $ | 7.13 |
Diluted earnings (loss) per share of common stock: |  |  |  |  |
Continuing operations | $ | 1.89 |  |  | $ | (1.88) |  |  | $ | 1.06 |
Discontinued operations | $ | 0.05 |  |  | $ | (0.19) |  |  | $ | 5.70 |
Total diluted earnings (loss) per share of common stock | $ | 1.95 |  |  | $ | (2.07) |  |  | $ | 6.76 |
Schedule of Weighted-Average Stock Options Not Included in Computation of Weighted-Average Diluted Shares Outstanding | The following weighted-average stock options were not included in the computation of weighted-average diluted shares outstanding because the effect would be anti-dilutive (in thousands):
| 2024 |  | 2023 |  | 2022
Number of stock options | 5,141 |  |  | 5,406 |  |  | 4,019 |
Schedule of Common Stock Share Activity | Common stock activity for 2024, 2023 and 2022 was as follows:
| 2024 |  | 2023 |  | 2022
Outstanding, beginning of year | 153,620,088 |  |  | 152,983,530 |  |  | 163,328,776 |
Issued from treasury | 960,437 |  |  | 817,110 |  |  | 5,711,974 |
Returned to treasury | (207,592) |  |  | (180,552) |  |  | (16,057,220) |
Outstanding, end of year | 154,372,933 |  |  | 153,620,088 |  |  | 152,983,530 |
Shares subject to the forward share purchase contract | (3,645,510) |  |  | (3,645,510) |  |  | (3,645,510) |
Outstanding, less shares subject to the forward share purchase contract | 150,727,423 |  |  | 149,974,578 |  |  | 149,338,020 |
Schedule of Common Stock Shares Reserved for Issuance Under Various Employee and Director Stock Plans | Common stock shares reserved for issuance under various employee and director stock plans at December 28, 2024 and December 30, 2023 are as follows:
| 2024 |  | 2023
Employee stock purchase plan | 921,982 |  |  | 1,070,126 |
Other stock-based compensation plans | 5,869,501 |  |  | 6,161,350 |
Total shares reserved | 6,791,483 |  |  | 7,231,476 |
Schedule of Weighted Average Assumptions Used to Value Grants | The following weighted-average assumptions were used to value grants made in 2024, 2023 and 2022:
| 2024 |  | 2023 |  | 2022
Average expected volatility | 38.0 | % |  | 39.1 | % |  | 38.6 | %
Dividend yield | 3.6 | % |  | 3.6 | % |  | 3.7 | %
Risk-free interest rate | 4.2 | % |  | 4.0 | % |  | 3.2 | %
Expected life | 5.0 years |  | 5.0 years |  | 4.2 years
Fair value per option | $ | 25.25 |  |  | $ | 26.05 |  |  | $ | 20.00 |
Weighted-average vesting period | 2.0 years |  | 1.9 years |  | 1.7 years
Schedule of Number of Stock Options and Weighted-average Exercise Prices | The number of stock options and weighted-average exercise prices as of December 28, 2024 are as follows:
| Options |  | Price
Outstanding, December 30, 2023 | 5,490,848 |  |  | $ | 133.22 |
Granted | 832,331 |  |  | 89.34 |
Exercised | (163,179) |  |  | 89.19 |
Forfeited | (241,429) |  |  | 125.24 |
Outstanding, December 28, 2024 | 5,918,571 |  |  | $ | 128.59 |
Exercisable, December 28, 2024 | 4,339,550 |  |  | $ | 140.93 |
Schedule of Outstanding and Exercisable Stock Option | Outstanding and exercisable stock option information at December 28, 2024 follows:
| Outstanding Stock Options |  | Exercisable Stock Options
Exercise Price Ranges | Options |  | Weighted- Average Remaining Contractual Life |  | Weighted- Average Exercise Price |  | Options |  | Weighted- Average Remaining Contractual Life |  | Weighted- Average Exercise Price
$100.00 and below | 2,183,691 |  |  | 8.46 |  | $ | 86.00 |  |  | 719,340 |  |  | 8.04 |  | $ | 82.46 |
100.01 — 165.00 | 2,055,411 |  |  | 3.38 |  | 131.22 |  |  | 2,040,881 |  |  | 3.35 |  | 131.38 |
165.01 — higher | 1,679,469 |  |  | 5.30 |  | 180.74 |  |  | 1,579,329 |  |  | 5.19 |  | 179.90 |
| 5,918,571 |  |  | 5.80 |  | $ | 128.59 |  |  | 4,339,550 |  |  | 4.80 |  | $ | 140.93 |
Schedule of Non-Vested Restricted Share Units and Activity Pertaining to Maximum Number of Shares that may be Issued | A summary of non-vested restricted share units and award activity as of December 28, 2024, and changes during the year then ended is as follows:
| Restricted Share Units & Awards |  | Weighted-Average Grant Date Fair Value
Non-vested at December 30, 2023 | 1,490,924 |  |  | $ | 100.24 |
Granted | 750,126 |  |  | 89.66 |
Vested | (585,745) |  |  | 99.85 |
Forfeited | (175,322) |  |  | 96.78 |
Non-vested at December 28, 2024 | 1,479,983 |  |  | $ | 95.44 |
A summary of the activity pertaining to the maximum number of shares that may be issued is as follows:
| LTIP Units |  | Weighted-Average Grant Date Fair Value
Non-vested at December 30, 2023 | 731,128 |  |  | $ | 119.90 |
Granted | 468,228 |  |  | 80.86 |
Vested | (15,562) |  |  | 163.45 |
Forfeited | (164,646) |  |  | 149.63 |
Non-vested at December 28, 2024 | 1,019,148 |  |  | $ | 96.50 |

X
- Definition Common Stock Outstanding Rollforward Disclosure [Table Text Block] + References No definition available. + Details
Name: | swk_CommonStockOutstandingRollforwardDisclosureTableTextBlock
Namespace Prefix: | swk_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of Share Based Payment Award Shares Authorized [Table Text Block] + References No definition available. + Details
Name: | swk_ScheduleOfShareBasedPaymentAwardSharesAuthorizedTableTableTextBlock
Namespace Prefix: | swk_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted Average Assumptions Used To Determine Fair Value Options Granted [Text Block] + References No definition available. + Details
Name: | swk_WeightedAverageAssumptionsUsedToDetermineFairValueOptionsGrantedTableTextBlock
Namespace Prefix: | swk_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration